| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |